Since the advent of cytotoxic chemotherapy in the treatment of patients with malignant disease there has been a need for a means of evaluating the response of an individual tumour to any particular drug or combination of drugs. Such a test will pinpoint a likely curative agent, and, at the same time, the harmful effects of inappropriate drugs will be avoided.
Various groups of workers have attempted to tackle this problem,1 2 and some successful correlation between in vitro and in vivo response has been reported. These studies have been carried out in specialised centres, often using sophisticated equipment and highly trained staff. In the present investigation we have enquired into the possibility of extending this type of work to the routine histology laboratory of a district general hospital.
The method of testing was based on a monolayer culture technique,3 and thus the first requirement was to establish a system for growing unselected tumour biopsy material in culture. We describe the technique adopted, based on the use of three disaggregation procedures, and discuss the application of the method to a simple cytotoxicity assay.
Material and methods
Specimens of tumours were obtained from operating theatres at Raigmore Hospital, Inverness, Royal Northern Infirmary, Inverness, Bignold Hospital, Wick, and Lewis Hospital, Stornoway. All types of Accepted for publication 20 August 1980 tumours were studied without selection. The range of tumours is listed in Table 1 . Specimens from Inverness hospitals were collected immediately from theatre. In the pathology laboratory a piece of tissue judged to be from the tumour was removed, adjacent to a block taken for routine histology.
Specimens from outside Inverness were either sent by air, unfixed, or else a portion of tumour was removed in theatre by the surgeon and placed in complete growth medium before being sent by air. Complete growth medium consisted of Medium 199 with Earles Salts with 20% Foetal Calf Serum and 10 ,ug/ml insulin, together with antibiotics. The antibiotic mixture included penicillin (250 units/ml); 343 streptomycin (250 ,ug/ml); gentamicin (50 ,tg/ml), and fungizone (2-5 ,g/ml) . These concentrations of antibiotics were halved once growth had been established.
The tissue was disaggregated by a method combining the techniques of Freshney3 and Lasfargues and Ozzello.4 From the initial sample, four different cell fractions were produced, one by mechanical means, one by trypsin, and two by collagenase. It was felt that the use of a series of disaggregation techniques should allow the maximum number of tumour cells to be released from the specimen.
The tissue was cut up finely in complete growth medium in a petri dish using crossed scalpels 'scissors fashion'. Care was taken to slice rather than chop the tissue as this leads to extensive cell damage. The pieces obtained (about 2 mm) together with the medium were transferred to a universal container and allowed to settle for a few minutes. The supernatant fluid, containing cells spilled out in the cutting process, was carefully removed. The fluid was centrifuged and the cells were suspended in 2 ml of completegrowth medium in a Nunc or Falcon 25 cm2 plastic flask.
The pieces were allowed to settle in two further changes of complete growth medium. They were then divided into two portions. The first aliquot was placed in a conical flask containing 0 5 % trypsin in Hanks's Balanced Salt Solution and left overnight at 4°C. After stirring for 1 hour at 37°C, the suspension was filtered through gauze and then spun down, the resulting cell pellet being suspended in 2 ml growth medium and set up for culture in a 25 cm2 culture flask.
The second aliquot was taken up in 10 ml complete growth medium containing 1 ,ug/ml collagenase (Sigma Chemical Co), and 5 ml was distributed into each of two 25 cm2 culture flasks. After Cells were plated into Falcon Microtest II multi-well plates at a density of 5-15000/well. Up to 96 replicate cultures were set up in the wells of the Microtest plate and, after growth was seen to be well established, the drugs to be tested were added to wells in a random fashion. Each drug was added to five wells, five control wells receiving medium only. The drug concentrations selected were an attempt to reproduce those found in vivo at the site of the tumour.5 6 The average daily dose per kilogram body weight was expressed on the assumption that a kilogram of body weight is equivalent to 1 litre of water. The concentrations used compared quite closely with those arrived at by other workers7 and are shown in Table2.
Cultures were incubated in the presence of drugs Melphalan for 18 to 24 hours. Drugs were then washed out with three changes of medium, and the cells were grown in medium only for three to four days to allow recovery, if any, to occur. All attached cells were assumed to be viable for the purpose of the test. The plastic-adherent cells in each well were then counted after trypsinisation, using a Fuchs-Rosenthal counting chamber. The number of cells from each treatment was compared with that from control wells. Any treatments giving a significantly lower mean by analysis of variance (p < 0-05) were considered to be effective for that tumour. In practice, this normally involved a reduction in cell numbers of at least 50 % compared with control wells.
Results and discussion
From Table 1 it can be seen that breast and gastrointestinal tumours predominate in the study, reflecting the surgery carried out in the area. base of the culture flask. Grade 2 Some of the cells were 'epithelial' type. Grade 3 'Epithelial' cells predominated in the culture, and sufficient growth was achieved to allow a drug sensitivity test to be carried out. It can be seen that grades 1 and 2 growth increased from tumour 61 onwards. Microbial contamination was markedly decreased after the 60th specimen, and the overall proportion of tumours giving suitable growth for drug testing increased throughout the period being studied. Specimen 60 marks the introduction of the collagenase disaggregation technique, and specimen 121 represents the introduction of insulin as a standard component of the medium. While these technical changes have undoubtedly played a major part in the increased rate of success, increasing expertise in handling the cells is a significant factor.
One of the major problems when using monolayer cultures as the basis of chemotherapy testing is identification of the cells as being 'tumour' cells or otherwise. We have used the criterion of epithelial or fibroblastic morphology in common with most other workers in the field. We assume that cells of 'fibroblastic' morphology constitute normal stromal cells from the tumour, while epithelial cells are considered to be of tumour origin, bearing in mind the known Of our breast tumours 47 % produced growth establishment in this way, and the kidney and ovary tumours were also reasonably successful. Thus, while it is obviously worthwhile retaining and culturing this cell fraction, many tumours will require further enzymic disaggregation in order to achieve successful growth of monolayers. This can be explained by observing how monolayer growth tends to arise in flasks. Almost invariably, growth arises by migration of cells from a small clump, or even quite a large piece of tissue, which has become attached to the base of the flask. It seems to be a very unusual event, certainly in the case of epithelial cells, for a single cell to become attached and subsequently to proliferate. Even in trypsinised preparations where there is a mixture of single cells and small clumps of tissue, it is usually by outgrowth from a piece of tissue, rather than by division of a single cell, that growth is initiated. The 'pieces' fraction left after collagenase digestion will have a number of suitable sized cell clusters for growth. The supernatant fraction, by its very nature, consists mainly of single cells or small groups which sediment only slowly in medium. Once again, however, there are usually enough suitable cell groups to produce growth from the supernatant fraction, as can be seen from Figure 2 .
FIBROBLAST OVERGROWTH
Since successful growth arises from groups of cells or pieces of tissue some fibroblast contamination seems inevitable. Pieces of tissue become attached to the plastic substratum of the flask, and if tumour cells are present they usually grow out first on to the base of the flask (Fig. 3) . Alternatively, fibroblast and tumour cells grow out simultaneously (Fig. 4) . In the case of breast tumours, the epithelial-type cells grow more quickly initially and are the predominant cell type, but eventually the fibroblast population engulfs the tumour cells. A drug sensitivity test can be carried out if tumour cells grow quickly enough within a short time before fibroblasts take over the cultures. Some cultures, notably from highly cellular tumours, are not so rapidly affected by fibroblast overgrowth and may continue as almost pure epithelial cell cultures for many weeks. In the end, however, all cultures succumb to fibroblast predominance.
Various approaches to the problem of fibroblast contamination have been suggested. 8 We have made attempts to separate fibroblasts using Ficoll gradients without success. We have also tried a low concentration of collagenase in the growth medium13 but found that using the enzyme at a high enough concentration to inhibit the growth of fibroblasts is equally damaging to epithelial cells. The ultimate solution may lie in producing a medium able to satisfy the exacting requirements of the tumour cells Buick et al.15 The use of a three-or four-day recovery period after removal of drugs may go some way towards reducing the discrepancy between metabolic and reproductive death measurements.
A total of 63 specimens had a suitable proportion of tumour cells to allow cytotoxicity testing to be carried out on microtest plate replicate cultures. The drugs tested on each tumour were chosen on the basis of the most common drugs used clinically for the particular tumour type in question. Altogether we tried 17 different drugs, and from five to nine were tested on each microtest plate. Cyclophosphamide could not be used because it needs in vivo activation to produce the anti-tumour metabolite.
Out of the 63 tests, cells showed no sensitivity to any drug tested on 42 occasions (67 %). Where sensitivity was shown, the number of successful drugs varied between one and eight. The frequency of the number of successful drugs for each tumour is shown in Figure 5 . It can be seen that most tumours are sensitive to a small number of drugs, only three out of 21 being sensitive to more than five drugs. This suggests that the method used is capable of discriminating between drugs, rather than simply showing a blanket cytotoxic effect. This is further illustrated in Table 4 , where the effectiveness of individual drugs is shown on the basis of the number of tests carried out. Actinomycin D is the most potent drug, while most of the others used exhibit a success rate of around 20-30% with varying effect in different tumours, as illustrated in Table 5 , which shows the results of drug tests on three different breast carcinomas. Table 6 shows the success rate of various agents when tested against cells from cultures of breast carcinoma only. Once again, actinomycin D is the most prominent, and the greater relative effectiveness of vinblastine in this tumour type is worthy of note.
